sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has released a Form 8.3 disclosure concerning its stake in Mural Oncology plc. The document, dated 20 November 2025, pertains to Rule 8.3 of the Irish Takeover Panel Act, 1997. The form reveals that The Vanguard Group holds 288,891 ordinary shares in Mural Oncology, equating to a 1.67% interest.
No additional disclosures are being made concerning other offer parties. Recent transactions include the purchase of 32 shares at $2.08 each. No cash-settled or stock-settled derivative activities were disclosed. The document also states no indemnity or option arrangements exist, nor are there any related agreements. A Supplemental Form 8 is not attached.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.